SCHEMBL5055437

SCHEMBL5055437

Cc1ccc(S(=O)(=O)n2nccc2C=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
ALDH1A1 P00352 6/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MCOLN3 Q8TDD5 2/20 0.45
GAA P10253 1/20 0.45
SLC9A1 P19634 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
KDM4E B2RXH2 1/20 0.41
UBE2N P61088 1/20 0.41
PKM P14618 2/20 0.41
ACHE P22303 1/20 0.41
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 2/20 0.40
MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024005 0.77 MAPT (0.47) MAPTALDH1A1NPSR1MCOLN3GAA
SCHEMBL28826711 0.76 MAPT (0.44) MAPTALDH1A1NPSR1MCOLN3GAA
SCHEMBL5062898 0.71 POLB (0.55) MAPTALDH1A1GAASLC9A1MEN1
SCHEMBL2457308 0.69 RAPGEF4 (0.58) ALDH1A1GAACA1CA2KDM4E
SCHEMBL1613458 0.68 ALDH1A1 (0.41) MAPTALDH1A1NPSR1MCOLN3GAA
SCHEMBL3318176 0.67 ALDH1A1 (0.43) MAPTALDH1A1NPSR1MCOLN3GAA
SCHEMBL568158 0.67 GRM4 (0.46) MAPTALDH1A1GAASLC9A1MEN1
SCHEMBL1580921 0.67 L3MBTL1 (0.50) ALDH1A1CA1CA2KDM4EUBE2N
SCHEMBL4170909 0.66 KDM4E (0.49) MAPTALDH1A1MCOLN3GAACA1
SCHEMBL15719870 0.65 MAPT (0.45) MAPTALDH1A1NPSR1MCOLN3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP claimed
EP-1891042-A2 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB Pharma, S.A. (BE) 2008-02-27 EP claimed
WO-2006128693-A2 2 -OXO-I -PYRROLIDINE DERIVATIVES/ PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO claimed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO claimed
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP disclosed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed